Learn More
Medchemexpress LLC Tranexamic acid | 1197-18-8 | 99.88% | 500 MG

Supplier: Medchemexpress LLC HYB0149500MG
Tranexamic acid, a cyclic analog of lysine, is an orally active antifibrinolytic agent that functions as a hemostatic agent. It attenuates the effects of severe trauma, inhibits urokinase plasminogen activator, and can ameliorate dry wrinkles. This compound is used in research for hemostasis studies and as a PROTAC linker.
- Attenuates effects of severe trauma by enhancing mitochondrial respiration, suppressing damage-associated molecular patterns (DAMPs) release, and improving capillary integrity.
- Inhibits cell migration in MDA-MB-231 breast cancer cells.
- Facilitates immune activation after traumatic brain injury in plasminogen-deficient mice.
- Decreases mast cell proliferation and increases fibroblast proliferation, ameliorating wrinkles caused by skin dryness in mice.
- Utilized in research for hemostasis studies.
- Serves as a PROTAC linker to synthesize PROTACs.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.